Internationalism No. 82, December 2025 Page 11 From the series Industry and pharmaceuticals On August 15 th , the White House published a long list of the most recent investments in American manufacturing. The statement emphasised the role of President Donald Trump who, with the aim of revitalising American industry [...], has spurred trillions of dollars of investments in US manufacturing, production, and innovation [ The White House, “Trump Effect: A Running List of New US Investment in President Trump’s Second Term” ]. The list includes around twenty pharmaceutical companies, which have announced a total commitment of over $340 billion in investments, more than half from European companies. Stephen Farrelly, an analyst at ING, estimates that investments in the United States announced by pharmaceutical multinationals amount to more than $400 billion [ Il Sole 24 Ore, October 15 th ]. Political pressures and old problems This i...